Patents by Inventor Magnus Björsne

Magnus Björsne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Patent number: 7772229
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: March 22, 2006
    Date of Patent: August 10, 2010
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, Kurt-Jürgen Hoffmann, Fritiof Pontėn, Gert Strandlund, Peder Svensson, Michael Wilsterman
  • Oxabispidine compounds useful in the treatment of cardiac arrhythmias
    Patent number: 7351821
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: December 18, 2006
    Date of Patent: April 1, 2008
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, David Cladingboel, Kurt-Jürgen Hoffmann, John Pavey, Fritiof Pontén, Gert Strandlund, Peder Svensson, Colin Thomson, Michael Wilsterman
  • 3,7-diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias
    Patent number: 7144914
    Abstract: There is provided compounds of formula (I) wherein R1 to R4, Ra to Rf, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: January 29, 2002
    Date of Patent: December 5, 2006
    Assignee: Astrazeneca AB
    Inventors: Magnus Björsne, Fritiof Pontén, Gert Strandlund, Peder Svensson, Michael Wilstermann
  • Bispidine compounds useful in the treatment of cardiac arrythmias
    Patent number: 6887881
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R5a, R5b, R6, X, A, B and D have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: June 15, 2000
    Date of Patent: May 3, 2005
    Assignee: AstraZeneca AB
    Inventors: Annika Björ, Magnus Björsne, Torbjörn Halvarsson, Kurt-Jürgen Hoffmann, Bertil Samuelsson, Gert Strandlund
  • Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
    Patent number: 6559162
    Abstract: Compounds of formula I, wherein R1, R2, R3 and Ra Rh are as defined in the specification. The compounds are useful in the prophylaxis and in the treatment of arrhythmias, in particular a trial and ventricular arrhythmias.
    Type: Grant
    Filed: February 28, 2001
    Date of Patent: May 6, 2003
    Assignee: AstraZeneca AB
    Inventors: Magnus Björsne, Fritiof Pontén, Gert Strandlund, Peder Svensson
  • Oxabispidine compounds useful in the treatment of cardiac arrhyythmias
    Patent number: 6559143
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3, R4, R41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: October 16, 2000
    Date of Patent: May 6, 2003
    Assignee: AstraZeneca AB
    Inventors: Annika Björe, Magnus Björsne, Kurt-Jürgen Hoffmann, Fritiof Pontén, Gert Strandlund, Peder Svensson, Michael Wilsterman
  • Bispidine antiarrhythmic compounds
    Patent number: 6291475
    Abstract: There is provided a compound of formula I, wherein R1, R2, R9, R10, R11, R12, X, A and B have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.
    Type: Grant
    Filed: January 12, 1999
    Date of Patent: September 18, 2001
    Assignee: AstraZeneca AB
    Inventors: Christer Alstermark, Annika Björe, Magnus Björsne, Marianne Frantsi, Torbjörn Halvarsson, Kurt-Jürgen Hoffmann, Eva-Lotte Lindstedt, Magnus Polla, Gert Strandlund